Trial
NCT02410239
MT2014-14 IT-MSC for Advanced Cerebral Adrenoleukodystrophy (cALD)
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
—
Condition
Cerebral Adrenoleukodystrophy
Intervention
Mesenchymal Stem Cells
Why stopped
Research cancelled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-12-02